Population
Patients with acute and chronic heart failure
Design
Cohort
Follow-up
1-year
Authors
Loading...
Persistent acute HF mortality risk warrants targeted strategies; this cohort study leaves open causal benefits of evidence-based chronic HF therapies.
The ESC-HF Pilot survey demonstrates that acute HF retains a poor prognosis, whereas evidence-based treatments have improved outcomes in chronic HF, with notable regional variations across Europe.
Maggioni et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: